What is Antigenix Therapeutics worth?
$15.0Mlast known valuation
Antigenix Therapeutics last raised $3.4M in its Seed Round (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Antigenix Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Seed Round | $3.4M | ▮ | ▮ |
How Antigenix Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Antigenix Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Antigenix Therapeutics worth?
- Antigenix Therapeutics's last known valuation is $15.0M.
- How much has Antigenix Therapeutics raised?
- Antigenix Therapeutics has raised $7.0M in total funding across 1 recorded rounds.
- When did Antigenix Therapeutics last raise?
- Antigenix Therapeutics last raised in Oct 2025 (Seed Round), raising $3.4M.